Efficacy and safety of rectal ibuprofen for patent ductus arteriosus closure in very low birth weight preterm infants
- 25 January 2017
- journal article
- research article
- Published by Taylor & Francis Ltd in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 30 (17), 2119-2125
- https://doi.org/10.1080/14767058.2016.1238897
Abstract
Background: To compare rectal ibuprofen with oral ibuprofen for the closure of hemodynamically significant patent ductus arteriosus (hsPDA) in very low birth weight (VLBW) preterm infants. Study design and subjects: In a prospective, randomized study, 72 VLBW infants who had hsPDA received either rectal or oral ibuprofen. The plasma concentration of ibuprofen and renal functions were determined in both groups by the high-performance liquid chromatography (HPLC) method and cystatin-C (cys-C), respectively. Results: The hsPDA closure rate of the group that received rectal ibuprofen was similar to oral ibuprofen (86.1% versus 83.3%) after the first course of the treatment (p = 0.745). A statistically significant difference was identified between the mean plasma cys-C levels before and after treatment in both the rectal and oral ibuprofen groups (p = 0.004 and p< 0.001, respectively). The mean plasma ibuprofen concentration was similar in both groups after the first dose (rectal 44.06 ± 12.4; oral, 48.28 ± 22.8) and the third dose (rectal, 45.34 ± 24.3; oral, 48.94 ± 24.8) (p > 0.05 for all values). Conclusions: Rectal ibuprofen is as effective as oral ibuprofen for hsPDA closure in VLBW infants. The rise in the cys-C level with rectal and oral treatment shows that patients with borderline renal function should be evaluated and followed closely.This publication has 31 references indexed in Scilit:
- Pharmacological Management of PDA: Oral Versus Intravenous MedicationsCurrent Clinical Pharmacology, 2012
- Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infantsArchives of Disease in Childhood: Fetal & Neonatal, 2011
- Patent ductus arteriosus in the preterm infant: to treat or not to treat?Journal of Perinatology, 2010
- Does Ibuprofen Increase Neonatal Hyperbilirubinemia?PEDIATRICS, 2009
- Oral Versus Intravenous Ibuprofen: Which Is Better in Closure of Patent Ductus Arteriosus?PEDIATRICS, 2009
- Oral-ibuprofen-induced acute renal failure in a preterm infantPediatric Nephrology, 2008
- Patent ductus arteriosus: pathophysiology and managementJournal of Perinatology, 2006
- The pharmacologic closure of the patent ductus arteriosusSeminars in Fetal and Neonatal Medicine, 2005
- Review of studies evaluating ductal patency in the premature infantThe Journal of Pediatrics, 1993
- Symptomatic patent ductus arteriosus in very-low-birth-weight infants: 1987–1989Early Human Development, 1991